Transcription of ICH Topic Q 1 A Stability Testing Guidelines: Stability ...
{{id}} {{{paragraph}}}
The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit CPMP/ICH/380/95. ICH Topic Q 1 A. Stability Testing Guidelines: Stability Testing of New drug Substances and Products Step 5. NOTE FOR GUIDANCE ON Stability Testing : Stability . Testing OF NEW drug SUBSTANCES AND PRODUCTS. (CPMP/ICH/380/95). [This guideline replaces relevant section of previous guideline]. APPROVAL BY CPMP December 1993. STUDIES CAN BE SUBMITTED ACCORDING TO THIS GUIDELINE January 1994. DATE FOR COMING INTO OPERATION 1 January 1998. (DOSSIERS SUBMITTED AFTER). ICH - Technical Coordination - R. Bass 7 Westferry Circus, Canary Wharf, London E14 4HB, UK. Tel: (+44-171) 418 84 11 Fax: (+44-171) 418 85 51. E_Mail: Stability Testing OF NEW drug SUBSTANCES. AND PRODUCTS. ICH Harmonised Tripartite Guideline [EMEA Status as of December 1993]. Preamble The following guideline sets out the Stability Testing requirement for a Registration Application within the three areas of the EC, Japan and the USA.
Information on the stability of the drug substance is an integral part of the systematic approach to stability evaluation. Stress Testing Stress testing helps to determine the intrinsic stability of the molecule by establishing degradation pathways in order to identify the likely degradation products and to validate the
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}